- Risk of Atherosclerosis in Patients with Ataxia Telangiectasia.
- Senataxin controls meiotic silencing through ATR activation and chromatin remodeling.
- Spontaneous ATM Gene Reversion in A-T iPSC to Produce an Isogenic Cell Line.
- T-cell ALL in ataxia telangiectasia cured with only 7 weeks of anti-leukemic therapy.
- Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective.
- Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab.
Seite 2 von 2
- 1
- 2